 |
|
|
| |
Effectiveness of 8 vs. 12 Week Ledipasvir/Sofosbuvir (LDV/SOF) in Black, Treatment Naïve Patients with Non-Cirrhotic, Genotype 1 HCV and Baseline Viral Load:
Analyses of Real-World Data from the TRIO Network
|
| |
| |
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
MICHAEL CURRY1, BRUCE BACON2 ,STEVEN FLAMM3, ANGELA LANDEN4, SCOTT MILLIGAN4, NAOKY TSAI5, ZOBAIR YOUNOSSI6 AND NEZAM AFDHAL1
1Beth Israel Deaconess Medical Center, 2Saint Louis University School of Medicine, 3Northwestern University Medical School, 4Trio Health Analytics, 5University of Hawaii; Queens Medical Center, 6Center for Liver Diseases, Department of Medicine, Inova Fairfax Hospital
|
| |
|
|
|
|
|
